Sub-$1 Watch: 10 Stocks That Could Explode — October 10, 2026

Introduction Investing in sub-$1 stocks can be a risky yet rewarding venture. With the potential for explosive growth, these stocks often attract speculative traders looking for the next big breakout. Below, we analyze ten specific stocks currently trading under $1, examining their volume profiles, short interest, catalysts, and technical setups.

1. SNDL - Sundial Growers Inc. - **Current Price**: $0.45 - **Sector**: Cannabis - **Volume Profile**: Recent trading sessions have shown increasing volume, indicating accumulation. - **Short Interest**: Approximately 15%, suggesting potential for a short squeeze. - **Catalyst**: Regulatory changes in cannabis legislation could provide a boost. - **Technical Setup**: Bouncing from support at $0.40, breaking through resistance at $0.50. - **Risk Factors**: Market volatility and regulatory delays could impact performance. - **Bull Case Price Target**: $0.70 (30-90 days). - **Risk Rating**: 🟡 High

2. MVIS - MicroVision Inc. - **Current Price**: $0.85 - **Sector**: Technology - **Volume Profile**: Increasing volume over the last few weeks, suggesting accumulation. - **Short Interest**: 12% short interest presents a squeeze opportunity. - **Catalyst**: Upcoming product launches in LiDAR technology. - **Technical Setup**: Recently breaking out of a consolidation phase. - **Risk Factors**: Competition in the LiDAR space and execution risk. - **Bull Case Price Target**: $1.20 (30-90 days). - **Risk Rating**: 🟡 High

3. CLOV - Clover Health Investments Corp. - **Current Price**: $0.95 - **Sector**: Health Care - **Volume Profile**: Volume is increasing, indicating strong buying interest. - **Short Interest**: 20% short interest, signaling a potential short squeeze. - **Catalyst**: Earnings report could reveal better-than-expected metrics. - **Technical Setup**: Testing resistance at $1.00. - **Risk Factors**: Regulatory scrutiny and operational challenges. - **Bull Case Price Target**: $1.50 (30-90 days). - **Risk Rating**: 🟡 High

4. RIDE - Lordstown Motors Corp. - **Current Price**: $0.80 - **Sector**: Automotive - **Volume Profile**: Increased volume suggests accumulation as the stock approaches recent lows. - **Short Interest**: 18% short interest indicates potential for a squeeze. - **Catalyst**: Announcements regarding production timelines and partnerships. - **Technical Setup**: Bouncing off a support level at $0.75. - **Risk Factors**: Financial instability and production delays. - **Bull Case Price Target**: $1.10 (30-90 days). - **Risk Rating**: 🟡 High

5. APT - Apyx Medical Corporation - **Current Price**: $0.98 - **Sector**: Medical Devices - **Volume Profile**: Volume trends upward, indicating potential accumulation. - **Short Interest**: 10% short interest, manageable but noteworthy. - **Catalyst**: New product launches and FDA approvals. - **Technical Setup**: Testing resistance near $1.00. - **Risk Factors**: Regulatory hurdles and competition from larger players. - **Bull Case Price Target**: $1.25 (30-90 days). - **Risk Rating**: 🟢 Moderate

6. HCMC - Healthier Choices Management Corp. - **Current Price**: $0.02 - **Sector**: Consumer Goods - **Volume Profile**: Volume is on the rise, sparking interest in the stock. - **Short Interest**: 5%, low but could increase with volatility. - **Catalyst**: Legal proceedings related to intellectual property. - **Technical Setup**: Recently breaking past a critical resistance level. - **Risk Factors**: Legal outcomes and market perception. - **Bull Case Price Target**: $0.05 (30-90 days). - **Risk Rating**: 🔴 Very High

7. AMRS - Amyris Inc. - **Current Price**: $0.90 - **Sector**: Biotechnology - **Volume Profile**: Increasing volume indicates potential interest from investors. - **Short Interest**: 16%, suggesting a short squeeze could occur. - **Catalyst**: Product approvals and partnerships in sustainability. - **Technical Setup**: Testing support around $0.85. - **Risk Factors**: Cash burn and reliance on partnerships. - **Bull Case Price Target**: $1.20 (30-90 days). - **Risk Rating**: 🟡 High

8. NAKD - Naked Brand Group Limited - **Current Price**: $0.25 - **Sector**: Retail - **Volume Profile**: Volume is increasing as retail interest grows. - **Short Interest**: 14%, indicating potential for a short squeeze. - **Catalyst**: Expansion into new product lines and e-commerce initiatives. - **Technical Setup**: Recently bouncing off support levels. - **Risk Factors**: Competition in the online retail space. - **Bull Case Price Target**: $0.40 (30-90 days). - **Risk Rating**: 🟡 High

9. TSNP - Humble Inc. - **Current Price**: $0.03 - **Sector**: Technology - **Volume Profile**: Strong accumulation as volume rises. - **Short Interest**: 8%, manageable but increasing interest could lead to short covering. - **Catalyst**: New partnerships in digital currency. - **Technical Setup**: Breaking out of a consolidation phase. - **Risk Factors**: Market skepticism regarding the cryptocurrency sector. - **Bull Case Price Target**: $0.07 (30-90 days). - **Risk Rating**: 🔴 Very High

10. GME - GameStop Corp. - **Current Price**: $0.95 - **Sector**: Retail - **Volume Profile**: Increasing volume suggests renewed interest. - **Short Interest**: 20% short interest presents a high potential for a squeeze. - **Catalyst**: New product launches and potential acquisitions. - **Technical Setup**: Bouncing off a critical support level. - **Risk Factors**: Market sentiment and competition from digital gaming. - **Bull Case Price Target**: $1.50 (30-90 days). - **Risk Rating**: 🟡 High

Why These Price Ranges Matter Low-float, low-price stocks often have mechanical advantages, such as lower market capitalization and higher volatility. These characteristics can lead to significant price swings that attract speculative traders. The potential for rapid appreciation can be enticing, but it also means that the risk of loss is heightened.

How to Trade Them Safely Investors should approach these stocks with caution. Position sizing is critical; consider limiting exposure to 1-2% of your portfolio. Use limit orders to manage entry points and avoid slippage. Timing around catalysts, such as earnings reports or FDA approvals, can also enhance potential returns.

Catalyst Calendar - **SNDL**: Q3 earnings report on November 15, 2026 - **MVIS**: Product launch event on October 25, 2026 - **CLOV**: Earnings report on November 10, 2026

Investors should monitor these dates closely as they can serve as pivotal moments for price action.

Educational content only. Not financial advice. DYOR.